TipRanks
Go Ultimate55% OFF

Reinsurance Group (RGA) AI Stock Analysis

MX:RGA

Reinsurance Group

(BMV:RGA)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue and premium growthRGA is expanding its revenue base while maintaining premium growth across multiple markets. Continued top-line progression and a healthy new-business pipeline can support scale benefits, reinforce insurer relationships, and provide a durable foundation for earnings growth over the next several quarters.
Negative Factors
Profitability and margin compressionThe deterioration in TTM margins and net income indicates that higher revenue has not translated proportionately into earnings. If weaker underwriting, claims or investment conditions persist, reduced profitability could constrain capital accumulation and make medium-term returns less reliable.

Reinsurance Group Business Overview & Revenue Model

Company Description

Reinsurance Group of America, Inc. (RGA) primarily operates within the reinsurance sector. The company delivers a comprehensive portfolio of life and health reinsurance products, spanning both individual and group coverages. These include diverse lif...

Reinsurance Group Earnings Call Summary

Earnings Call Date:Aug 05, 2026(Q2-2026)|Next Earnings Date:Nov 04, 2026
Earnings Call SentimentPositive

The call emphasized a record operating quarter driven by strong investment returns, favorable claims experience, healthy new business and disciplined capital deployment (nearly $500M deployed YTD, $2.2B excess capital, buybacks/dividend increase). Management highlighted durable strategic advantages, strong VII/alternative performance, and continued confidence in intermediate-term targets (8%-10% EPS growth, 13%-15% ROE). Lowlights were largely operational nuances and one-time benefits: measured traditional premium growth was modest due to deliberate in-force management, a $35M corporate segment loss, and a $71M one-time uplift. Additional concerns noted include rising asset-intensive activity (asset leverage), geopolitical uncertainty in Hong Kong/MCB, and the reliance on elevated investment/alternative returns to sustain outperformance. Overall, positives materially outweigh the challenges described.

Positive Updates

Record Quarter and Key Financial Metrics
Pre-tax adjusted operating income of $761 million for the quarter; earnings of $8.89 per share after tax; adjusted operating return on equity of 18.4% (trailing 12 months, excluding AOCI and notable items).

Negative Updates

Traditional Premium Growth Impacted by In-Force Actions
Traditional premiums were modest overall: traditional premium growth was 2.2% (0.9% constant currency). Management noted in-force management actions reduced measured traditional premium growth (but improved earnings profile).

Company Guidance

RGA reiterated confidence in its intermediate-term targets—8%–10% EPS growth, 13%–15% ROE and a 20%–30% payout ratio—while forecasting a 7% planned VII return for 2026 (though VII delivered ~15% annualized in Q2 and ~11% YTD); the quarter produced $761M pre-tax adjusted operating income ($8.89 per share after tax) and a trailing‑12‑month adjusted operating ROE of 18.4% (ex‑AOCI/notables). Management highlighted investment strength with a core portfolio yield of 4.96% and a new‑money rate of 6.02%, nearly $500M deployed into in‑force transactions year‑to‑date ($158M this quarter), $111M returned to shareholders this quarter ($50M buybacks, $61M dividends) and $2.2B of excess capital (with $400M planned to pay down debt in September), plus a 5.4% dividend increase; other metrics included total premiums ex‑PRT YTD up 10.5% (9.3% cc), traditional premiums +2.2% (0.9% cc), U.S. total premium ex‑PRT ~8%, capped cohort exposure down 25% since LDTI, book value per share ex‑AOCI/B36 $174.11 (10.1% CAGR since 2021), and $31M of economic claims favorability (≈$14M benefit to current earnings).

Reinsurance Group Risk Analysis

Reinsurance Group disclosed 37 risk factors in its most recent earnings report. Reinsurance Group reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Reinsurance Group Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

MX:RGA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
RNRRNR76Outperform$13.71B9.9913.52%0.46%-21.18%-3.27%
SPNTSPNT76Outperform$3.01B6.2721.84%―22.55%371.77%
HGHG75Outperform$3.44B6.8123.92%―19.62%22.42%
GLREGLRE68Neutral$478.52M8.727.28%―-0.85%32.35%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
EGEG65Neutral$15.76B8.8912.52%1.92%-8.72%250.85%

* Financial Sector Average

Performance Comparison

0%20%40%EGGLRERNRSPNTHGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MX:RGA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
EGEverest Group, Ltd.417.72103.3732.88%
GLREGreenlight Capital Re15.092.8423.18%
RNRRenaissancere350.9485.0331.98%
SPNTSiriuspoint Ltd26.016.5933.93%
HGHamilton Insurance Group, Ltd. Class B36.2811.9949.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.